Health 2.0

ONC Invests in Innovation Challenges

By

Health 2.0 is thrilled to announce that we are launching two challenges as part of the official kick-off of the Investing in Innovation (i2) program. Over the next 2 years the ONC will be issuing nearly $2 million in prize money for numerous challenges all designed to inspire innovation in health information technology. Along with our colleagues at Capital Consulting Corporation, Health 2.0 is the contractor supporting this effort. We started with a joint NCI/ONC effort which is already underway, but now the first two challenges are live. And they are:

  • Reporting Device Adverse Events Challenge ONC is asking multi-disciplinary teams to develop an application that facilitates the reporting of adverse events related to medical devices, whether implanted or used in the hospital, clinic, or home. This challenge has $40,000 in total prizes
  • Ensuring Safe Transitions from Hospital to Home Challenge. ONC is challenging software developers to improve care transitions and build upon these tools by generating an intuitive and easy-to-use application to empower patients and caregivers that fits into existing ways that providers communicate. This challenge also has $40,000 in total prizes.

These are both critical parts of health care where new innovation can make a big difference–and developers can win a substantial prize to get them on their way.

Livongo’s Post Ad Banner 728*90

Categories: Health 2.0, THCB

Tagged as: , ,

1
Leave a Reply

1 Comment threads
0 Thread replies
0 Followers
 
Most reacted comment
Hottest comment thread
1 Comment authors
Zakkiyya Asad Recent comment authors
newest oldest most voted
Zakkiyya Asad
Guest
Zakkiyya Asad

As a technologist that does a lot of work related to adverse event reporting I applaud the Reporting Device Adverse Event Challenge that is being proposed by the ONC, however I believe the real technical challenge that would benefit patients before they experience adverse events would be a reporting system that tracks devices approved through the 510K approval process. Simply described the 510K approval process allows a manufacturer to stipulate that their product operates essentially like another product that has already passed FDA scrutiny, therefore it does not need further safety testing prior to release. A prime example is the… Read more »